Stock Events

Stock Events

Aligos Therapeutics (ALGS) Q1 2026 Earnings

5MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-3.04

-2.54

-2.03

-1.53

Details

Expected EPS

-2.486749

Actual EPS

-1.91

Surprise EPS

0.58

Surprise Percent

+23.19%

Description

Aligos Therapeutics (ALGS) has reported earnings of -1.91 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.